Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
73,759,772
-
Shares change
-
+10,598,906
-
Total reported value, excl. options
-
$1,145,458,451
-
Value change
-
+$162,122,671
-
Put/Call ratio
-
111%
-
Number of buys
-
81
-
Number of sells
-
54
-
Price
-
$15.53
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2019
As of 30 Sep 2019 FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) had 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 73,759,772 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, FMR LLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, STATE STREET CORP, Casdin Capital, LLC, FRANKLIN RESOURCES INC, and Grosvenor Holdings, L.L.C..
This table shows 166 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.